The thalassaemias are a heterogenous group of inherited blood disorders with the commonality of impaired haemoglobin synthesis, resulting in ineffective erythropoiesis and haemolysis. These may result in the development of lifelong anaemia, comorbidities, and complications. Thalassaemias can place a large burden on patients and their quality of life, with significant demands on healthcare resources, while management of the disease can be complex.
EMJ Hematology 11 [Supplement 4] . 2023
August 2023
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given